Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

The Case for Sites Using Their Own Tech to Accelerate Research and Reduce Burden

  • Broadcast in Science
Pharma Talk Radio

Pharma Talk Radio

×  

Follow This Show

If you liked this show, you should follow Pharma Talk Radio.
h:548881
s:12053771
archived

About the Episode: 

In this podcast, we discuss the topic of clinical sites shifting to using the own technologies in sponsored trials and how it can advance (and maintain the pace of) clinical research. Our guest, Bryan Spielman, Chief Growth Officer at Advarra lays out the current burden being faced by performing sponsor trials. Mr Spielman also talks about the work Advarra has led in bringing together sites, CROs and sponsors to brainstorm new solutions, and the path forward to encourage wider conversation, acceptance and adoption.

 

Key Takeaways:

  • Identifying current burdens faced by sites
  • Understanding current attitudes towards site-owned technology
  • Steps forward to benefit both sides of clinical research

 

About the Speaker: 

Bryan Spielman, MBA, is Chief Growth Officer at Advarra and is responsible for driving Advarra’s corporate strategy, mergers and acquisitions, strategic partnerships, and corporate marketing. Spielman brings over 25 years of business development and corporate strategy experience from leading technology companies including those with a focus on life sciences.

 

For more information about innovation in clinical research, click here

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled